(CercleFinance.com) – Reckitt Benckiser yields nearly 1% in London, despite favorable comments from UBS, which reaffirms its ‘buy’ recommendation, as well as its price target of 8,000 pence on the title of the British health products group and maintenance.
While the press is suggesting initial offers for its infant nutrition business, the broker believes that the sale of this business ‘could improve Reckitt’s operating margin profile, thus ensuring the achievement of medium-term objectives’.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
